Bristol Myers Squibb

Anthropic Claude AI business integration and adoption

9 clusters · 148 sources · last updated 2 days ago

Latest: Anthropic releases Claude Code agentic coding tool

Anthropic’s Claude AI is being integrated into corporate environments through specialized enterprise services and tiered subscription models. In Japan, Mizuho Financial Group announced ‘Mizuho Cowork’, an autonomous AI a

Mayo Clinic pancreatic cancer vaccine clinical trial

3 clusters · 11 sources · last updated 2 days ago

Latest: BioNTech and Camupepimut report clinical trial results for cancer treatments

Researchers at Mayo Clinic have reported promising results from a phase 2 clinical trial of an investigational, ‘off the shelf’ vaccine designed to target KRAS mutations in pancreatic ductal adenocarcinoma. The study, pu

US-China technology and trade restrictions

9 clusters · 87 sources · last updated 8 days ago

Latest: US proposes expanding investment restrictions on China to include biotechnology

The United States is intensifying efforts to restrict China’s access to critical technologies necessary for artificial intelligence development. Recent reports indicate potential new controls on semiconductor equipment,

Multiple myeloma Phase 3 clinical trial developments

2 clusters · 3 sources · last updated 9 days ago

Latest: Pfizer reports positive Phase 3 trial results for Elrexfio in myeloma

Recent clinical developments in multiple myeloma treatment have seen positive Phase 3 trial results from major pharmaceutical companies. Bristol Myers Squibb reported that its Zenbexus regimen, used in combination with

Clinical applications and access of CAR-T and myeloma cell/m

21 clusters · 74 sources · last updated 9 days ago

Latest: CAR T-cell therapy shows promise for hairy cell leukemia

CAR-T cell therapy continues to expand its clinical utility across oncology and autoimmune diseases. In oncology, the therapy is transforming treatment for aggressive lymphomas and resistant blood cancers. A significant

Cell and gene therapy industry development

3 clusters · 6 sources · last updated 25 days ago

Latest: Cell and gene therapy industry shifts toward scalable manufacturing

The cell and gene therapy (CGT) sector is shifting its focus from scientific validation toward overcoming logistical, economic, and manufacturing hurdles. Initially, industry discussions centered on the need for integrat